CD36 is a scavenger receptor involved in various cellular processes, including lipid uptake, cell adhesion, and innate immunity. This transmembrane glycoprotein is ubiquitous in various cell types, including adipocytes, monocytes, and platelets. Its role in fatty acid uptake makes it an important player in lipid metabolism. Chemicals activating CD36 mostly aim to either enhance its expression on the cell membrane or increase its affinity to bind ligands like long-chain fatty acids. Palmitic acid, for instance, is a natural ligand that directly engages CD36, thereby driving downstream cellular events like lipid uptake and signaling. In contrast, compounds like Fenofibrate and WY-14643 act through peroxisome proliferator-activated receptors (PPARs), leading to increased CD36 expression.
Anisomycin and Thapsigargin focus on intracellular pathways, either affecting calcium levels or activating kinases that then affect CD36 function. This is particularly insightful because it suggests a broad but interconnected range of chemical tactics for activating CD36. For instance, Cerulenin leads to an increase in CD36 surface expression by inhibiting fatty acid synthesis, thereby shifting cellular machinery to uptake fatty acids from the external environment. Quercetin, a polyphenolic flavonoid, is intriguing for its ability to activate the AMPK pathway, which is known to regulate CD36 expression.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palmitic Acid | 57-10-3 | sc-203175 sc-203175A | 25 g 100 g | $112.00 $280.00 | 2 | |
Directly binds to CD36, increasing fatty acid uptake and signaling. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Increases cytosolic calcium, thereby indirectly activating CD36. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates p38 MAPK pathway, affecting CD36 expression and activation. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $158.00 $306.00 $1186.00 | 9 | |
Fatty acid synthase inhibitor that can lead to increased CD36 surface expression. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
PPARα agonist, increases CD36 expression and enhances fatty acid uptake. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $96.00 $334.00 | 50 | |
Binds to GPCRs that indirectly enhance CD36-mediated cellular processes. | ||||||
GW 9662 | 22978-25-2 | sc-202641 | 5 mg | $68.00 | 30 | |
PPARγ antagonist, indirectly enhances CD36 expression. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Increases CD36 expression by activating the AMPK pathway. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
PPARγ agonist, can significantly increase CD36 expression. | ||||||
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $133.00 | 7 | |
A synthetic PPARα agonist that upregulates CD36 expression. | ||||||